This report contains market size and forecasts of Pediatric Respiratory Disease Therapeutics in Global, including the following market information:
Global Pediatric Respiratory Disease Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pediatric Respiratory Disease Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Inflammatory Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pediatric Respiratory Disease Therapeutics include Novartis AG, Bayer AG, GSK, Merck, Boehringer Ingelheim, Regeneron Pharmaceuticals, AstraZeneca and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediatric Respiratory Disease Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatric Respiratory Disease Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pediatric Respiratory Disease Therapeutics Market Segment Percentages, by Type, 2021 (%)
Anti-Inflammatory Drugs
Bronchodilators
Combination Drugs
Corticosteroid
Monoclonal Antibodies
Others
Global Pediatric Respiratory Disease Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pediatric Respiratory Disease Therapeutics Market Segment Percentages, by Application, 2021 (%)
Asthma
Cystic Fibrosis
Bronchiolitis
Pneumonia
Idiopathic Pulmonary Fibrosis
Tuberculosis
Others
Global Pediatric Respiratory Disease Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pediatric Respiratory Disease Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatric Respiratory Disease Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pediatric Respiratory Disease Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Bayer AG
GSK
Merck
Boehringer Ingelheim
Regeneron Pharmaceuticals
AstraZeneca
Roche